Piramal Pharma to acquire G&W’s US drug unit for $17.5mn
This acquisition will expand Piramal Pharma’s product offerings by adding solid oral dosage form capabilities (tablets and capsules) in North America.
Biocon enters into a licensing agreement with DKSH
Under this agreement, DKSH will sell and distribute seven of Biocon Pharma's generic formulations in Singapore and Thailand.
Roche Pharma expands partnership with Cipla
Under this agreement, Cipla will be responsible for the marketing and distribution of Roche’s key trademark oncology drugs in the Indian market.
Glenmark gets final USFDA nod for Fingolimod capsules
Glenmark's current portfolio consists of 164 products authorised for distribution in the American market.
Interview: Global Indian CEO on trials to find a Covid-19 cure
Dr Someit Sidhu is the Co-Founder and CEO of Izana Bioscience, an Oxford-based biopharmaceutical company which is part of a major new UK drugs trial to test potential therapeutics to treat patients hospitalised with Covid-19.
Zydus Cadila inks pact with Gilead for remdesivir
This makes Zydus the fifth company in India and sixth in the world to sign licensing agreement for Gilead’s anti-viral drug.
Carlyle Group may buy stake in Piramal’s pharma business
Carlyle Group might buy minority stake in Piramal’s pharmaceuticals business for up to $525 million.
Cipla to buy 22% stake in GoApptiv for $1.19mn
The deal will help Cipla to expand the reach of its key brands in tier-3 plus towns.
Tilting closer towards Uncle Sam
The close cooperation between India and the US on ways to combat COVID-19 stands in sharp contrast to India’s transactional ties with China. Highlights: Given the long history of wariness in Indo-Chinese ties, India is building a strong partnership with the US to find ways to combat the virus. While the government has made common cause with the US on several issues, it has also finessed its foreign policy to maintain a functional working relationship with China. The cooperation with [...]
A lockdown in China can cause supply chain disruptions
The spread of Coronavirus will adversely affect the aviation, pharmaceutical and automobile industries in India, among others. Lockout in parts of China following Coronavirus outbreak will have an adverse impact on several industries in India – aviation, pharmaceutical and automobile being three of them. Impact on Indian aviation industry Till recently, the outbreak of the Coronavirus was limited to China and some of the other South East (SE) Asian countries and has impacted the air travel and movement of freight [...]